{
  "pmcid": "6630065",
  "abstract": "300-word version:\n\nTitle: Randomised Controlled Trial on Imaging Surveillance After Endovascular Aortic Repair\n\nBackground: This study aimed to assess the impact of compliance with imaging surveillance on reintervention rates and mortality in patients who have undergone endovascular aortic repair (EVAR).\n\nMethods: A systematic review and meta-analysis were conducted on 11 retrospective cohort studies, encompassing 21,838 patients. The studies compared patients compliant with imaging surveillance protocols to those who were partially or noncompliant. The primary outcome was the reintervention rate, and the secondary outcome was all-cause mortality, both measured over a median follow-up of 31.7 months. The review protocol was registered at PROSPERO (CRD42017080494).\n\nResults: The overall reintervention rate was 5%, with a risk difference (RD) of 4% (95% CI 1% to 7%) favoring partial/noncompliance, indicating a number needed to harm of 25 (95% CI 14 to 100). The overall mortality rate was 31%, with a nonsignificant RD of 12% (95% CI âˆ’2% to 26%) in favor of partial/noncompliance. Two studies reported that 41% to 53% of reinterventions were due to complications detected through imaging surveillance, while others were detected through patient symptoms.\n\nInterpretation: The findings suggest that compliance with imaging surveillance after EVAR results in more reinterventions without a corresponding reduction in mortality. This indicates that the current recommendation for yearly imaging surveillance may not be universally beneficial for all EVAR patients. The study underscores the importance of developing a more individualized approach to post-EVAR surveillance, potentially reducing unnecessary interventions and associated complications.\n\nTrial registration: PROSPERO CRD42017080494\n\nFunding: Not specified.",
  "word_count": 250
}